Case Study: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Diagnosis: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A 49-year-old man received a Tdap vaccine and, two weeks later, an MMR vaccine. Approximately four weeks after his first vaccine and two weeks after the second, he began to experience numbness and tingling in his fingers and toes. Over the next several weeks, numbness ascended to include his feet, thighs, back, hands and nose. The petitioner was referred to a neurologist for evaluation and electrodiagnostic testing. His symptoms progressed to include weakness and fatigue, and he was diagnosed with CIDP. He has been treated with IVIG, and is expected to receive frequent IVIG treatments for life.

Result: Petitioner was awarded $960,000, inclusive of past and future medical expenses, lost wages and pain and suffering.